John Armitage
Egerton Capital
John Armitage Bath & Body Works Inc stake
total: 222
Egerton Capital BBWI trades
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 5
- Reduced:
- 4
- Held since:
- 2020 Q1
- Held for:
- 10 quarters
- Latest activity:
- 2022 Q3
According to 2026 Q2 report, John Armitage doesn't hold any Bath & Body Works Inc (BBWI) shares. To date, the estimated cost basis is nearly $24.07 for "buy" trades and estimated average "sell" price is $35.56. Egerton Capital first purchased BBWI in 2020 Q1, initially acquiring about 7.67M shares. Since the initial investment in Bath & Body Works Inc (BBWI), Egerton Capital has made 10 more transactions.
When did John Armitage sell Bath & Body Works Inc (BBWI)?
John Armitage sold off the entire Bath & Body Works Inc (BBWI) position in 2022 Q3.
When did John Armitage buy Bath & Body Works Inc (BBWI)?
John Armitage first invested in Bath & Body Works Inc (BBWI) in 2020 Q1 at the reported quarter-end price of $11.56 per share.
What's the cost basis of Egerton Capital's BBWI stake?
The estimated cost basis for Bath & Body Works Inc (BBWI) stake is around $24.07 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $24.07
- Weighted AVG sell price:
- $35.56
John Armitage's historical trades in Bath & Body Works Inc
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$26.92
|
|
-100% (-7,474,211)
|
-1.36%
|
|
2022 Q2
|
1.36%
|
7,474,211
|
$26.92
|
$201,206,000
|
-45.15% (-6,151,546)
|
-0.87%
|
|
2022 Q1
|
3.43%
|
13,625,757
|
$47.80
|
$651,311,000
|
-0.33% (-45,530)
|
-0.01%
|
|
2021 Q4
|
4.45%
|
13,671,287
|
$69.79
|
$954,119,000
|
-3.08% (-435,089)
|
-0.14%
|
|
2021 Q3
|
4.23%
|
14,106,376
|
$63.03
|
$889,125,000
|
+8.31% (+1,082,199)
|
+0.32%
|
|
2021 Q2
|
4.67%
|
13,024,177
|
$72.06
|
$938,522,000
|
-17.70% (-2,801,113)
|
-1.06%
|
|
2021 Q1
|
5.16%
|
15,825,290
|
$61.86
|
$978,952,000
|
+0.04% (+5,544)
|
+0%
|
|
2020 Q4
|
3.33%
|
$37.19
|
+8.78% (+1,276,710)
|
|||
|
2020 Q3
|
2.86%
|
$31.81
|
+68.22% (+5,897,656)
|
|||
|
2020 Q2
|
0.96%
|
$14.97
|
+12.75% (+977,493)
|
|||
|
2020 Q1
|
0.92%
|
$11.56
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.